• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LabKey Server NAb:一种用于分析、可视化和共享中和抗体检测结果的工具。

LabKey Server NAb: a tool for analyzing, visualizing and sharing results from neutralizing antibody assays.

机构信息

LabKey Software, Seattle, Washington 98102, USA.

出版信息

BMC Immunol. 2011 May 27;12:33. doi: 10.1186/1471-2172-12-33.

DOI:10.1186/1471-2172-12-33
PMID:21619655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3115917/
Abstract

BACKGROUND

Multiple types of assays allow sensitive detection of virus-specific neutralizing antibodies. For example, the extent of antibody neutralization of HIV-1, SIV and SHIV can be measured in the TZM-bl cell line through the degree of luciferase reporter gene expression after infection. In the past, neutralization curves and titers for this standard assay have been calculated using an Excel macro. Updating all instances of such a macro with new techniques can be unwieldy and introduce non-uniformity across multi-lab teams. Using Excel also poses challenges in centrally storing, sharing and associating raw data files and results.

RESULTS

We present LabKey Server's NAb tool for organizing, analyzing and securely sharing data, files and results for neutralizing antibody (NAb) assays, including the luciferase-based TZM-bl NAb assay. The customizable tool supports high-throughput experiments and includes a graphical plate template designer, allowing researchers to quickly adapt calculations to new plate layouts. The tool calculates the percent neutralization for each serum dilution based on luminescence measurements, fits a range of neutralization curves to titration results and uses these curves to estimate the neutralizing antibody titers for benchmark dilutions. Results, curve visualizations and raw data files are stored in a database and shared through a secure, web-based interface. NAb results can be integrated with other data sources based on sample identifiers. It is simple to make results public after publication by updating folder security settings.

CONCLUSIONS

Standardized tools for analyzing, archiving and sharing assay results can improve the reproducibility, comparability and reliability of results obtained across many labs. LabKey Server and its NAb tool are freely available as open source software at http://www.labkey.com under the Apache 2.0 license. Many members of the HIV research community can also access the LabKey Server NAb tool without installing the software by using the Atlas Science Portal (https://atlas.scharp.org). Atlas is an installation of LabKey Server.

摘要

背景

多种类型的检测方法可用于敏感地检测病毒特异性中和抗体。例如,可以通过感染后荧光素酶报告基因表达的程度,在 TZM-bl 细胞系中测量 HIV-1、SIV 和 SHIV 的抗体中和程度。过去,该标准检测的中和曲线和滴度是使用 Excel 宏计算的。使用新技术更新此类宏的所有实例可能很麻烦,并且会导致多实验室团队之间的不一致性。使用 Excel 还会在集中存储、共享和关联原始数据文件和结果方面带来挑战。

结果

我们介绍了 LabKey Server 的 NAb 工具,用于组织、分析和安全共享中和抗体(NAb)检测数据、文件和结果,包括基于荧光素酶的 TZM-bl NAb 检测。该可定制工具支持高通量实验,包括图形板模板设计器,允许研究人员快速适应新板布局的计算。该工具根据发光测量值计算每个血清稀释度的中和百分比,拟合一系列中和曲线以得出滴定结果,并使用这些曲线估算基准稀释度的中和抗体滴度。结果、曲线可视化和原始数据文件存储在数据库中,并通过安全的基于 Web 的界面共享。可以根据样品标识符将 NAb 结果与其他数据源集成。发布后,通过更新文件夹安全设置,可以轻松公开结果。

结论

用于分析、存档和共享检测结果的标准化工具可以提高许多实验室获得的结果的可重复性、可比性和可靠性。LabKey Server 及其 NAb 工具可在 http://www.labkey.com 上免费获得,可根据 Apache 2.0 许可证获得开源软件。许多 HIV 研究界成员也可以通过使用 Atlas Science Portal(https://atlas.scharp.org)访问 LabKey Server NAb 工具,而无需安装软件。Atlas 是 LabKey Server 的一个安装。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/f3401c2f7e9f/1471-2172-12-33-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/7606ffc77a2f/1471-2172-12-33-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/7b5d06ac3f4a/1471-2172-12-33-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/0b4f892e43bb/1471-2172-12-33-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/d676283e0306/1471-2172-12-33-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/f448fa72c03b/1471-2172-12-33-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/bf9f0a42a006/1471-2172-12-33-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/f3401c2f7e9f/1471-2172-12-33-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/7606ffc77a2f/1471-2172-12-33-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/7b5d06ac3f4a/1471-2172-12-33-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/0b4f892e43bb/1471-2172-12-33-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/d676283e0306/1471-2172-12-33-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/f448fa72c03b/1471-2172-12-33-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/bf9f0a42a006/1471-2172-12-33-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9be/3115917/f3401c2f7e9f/1471-2172-12-33-7.jpg

相似文献

1
LabKey Server NAb: a tool for analyzing, visualizing and sharing results from neutralizing antibody assays.LabKey Server NAb:一种用于分析、可视化和共享中和抗体检测结果的工具。
BMC Immunol. 2011 May 27;12:33. doi: 10.1186/1471-2172-12-33.
2
Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform.使用开源 LabKey Server 平台进行 Luminex®免疫分析数据的质量控制、分析和安全共享。
BMC Bioinformatics. 2013 Apr 30;14:145. doi: 10.1186/1471-2105-14-145.
3
LabKey Server: an open source platform for scientific data integration, analysis and collaboration.LabKey Server:一个用于科学数据集成、分析和协作的开源平台。
BMC Bioinformatics. 2011 Mar 9;12:71. doi: 10.1186/1471-2105-12-71.
4
Installation and use of LabKey Server for proteomics.用于蛋白质组学的LabKey服务器的安装与使用。
Curr Protoc Bioinformatics. 2011 Dec;Chapter 13:13.5.1-13.5.25. doi: 10.1002/0471250953.bi1305s36.
5
Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay.使用TZM-bl检测法测定的赋予猕猴针对猿猴/人类免疫缺陷病毒攻击的中和抗体滴度。
AIDS Res Hum Retroviruses. 2010 Jan;26(1):89-98. doi: 10.1089/aid.2009.0144.
6
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.优化和验证 TZM-bl 测定法,用于标准化评估抗 HIV-1 的中和抗体。
J Immunol Methods. 2014 Jul;409:131-46. doi: 10.1016/j.jim.2013.11.022. Epub 2013 Dec 1.
7
Measuring HIV neutralization in a luciferase reporter gene assay.在荧光素酶报告基因检测中测量HIV中和作用。
Methods Mol Biol. 2009;485:395-405. doi: 10.1007/978-1-59745-170-3_26.
8
Panorama: a targeted proteomics knowledge base.全景图:一个靶向蛋白质组学知识库。
J Proteome Res. 2014 Sep 5;13(9):4205-10. doi: 10.1021/pr5006636. Epub 2014 Aug 18.
9
International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.国际技术转移:符合 GCLP 的 HIV-1 中和抗体检测用于人体临床试验。
PLoS One. 2012;7(1):e30963. doi: 10.1371/journal.pone.0030963. Epub 2012 Jan 27.
10
Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.开发一种基于高通量β-半乳糖苷酶的中和试验,用于定量检测人样本中的单纯疱疹病毒中和抗体。
Vaccine. 2016 Jul 19;34(33):3901-6. doi: 10.1016/j.vaccine.2016.05.033. Epub 2016 Jun 15.

引用本文的文献

1
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.一种综合工程策略提高了一种近乎泛中和的抗HIV抗体的效力和可制造性。
Structure. 2025 Jul 3;33(7):1150-1164.e8. doi: 10.1016/j.str.2025.04.016. Epub 2025 May 14.
2
Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2.通过增加 V2 上的 Ab-Ag 界面提高对多种 HIV-1 的中和广度。
Adv Sci (Weinh). 2022 May;9(15):e2200063. doi: 10.1002/advs.202200063. Epub 2022 Mar 23.
3
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

本文引用的文献

1
LabKey Server: an open source platform for scientific data integration, analysis and collaboration.LabKey Server:一个用于科学数据集成、分析和协作的开源平台。
BMC Bioinformatics. 2011 Mar 9;12:71. doi: 10.1186/1471-2105-12-71.
2
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.对多样化的 HIV-1 Env 假病毒进行分层分类,以评估中和抗体。
J Virol. 2010 Feb;84(3):1439-52. doi: 10.1128/JVI.02108-09. Epub 2009 Nov 25.
3
Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients.
严重急性呼吸综合征冠状病毒2型铁蛋白纳米颗粒疫苗引发广泛的严重急性呼吸综合征冠状病毒免疫原性。
Cell Rep. 2021 Dec 21;37(12):110143. doi: 10.1016/j.celrep.2021.110143. Epub 2021 Dec 8.
4
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.严重急性呼吸综合征冠状病毒2型铁蛋白纳米颗粒疫苗引发广泛的严重急性呼吸综合征冠状病毒免疫原性。
bioRxiv. 2021 May 10:2021.05.09.443331. doi: 10.1101/2021.05.09.443331.
5
Eight practices for data management to enable team data science.实现团队数据科学的数据管理八项实践。
J Clin Transl Sci. 2020 Jun 23;5(1):e14. doi: 10.1017/cts.2020.501.
6
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.一种主要识别 N 连接糖基的中和抗体靶向 HIV 包膜的静默面。
Immunity. 2018 Mar 20;48(3):500-513.e6. doi: 10.1016/j.immuni.2018.02.013. Epub 2018 Mar 13.
7
Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells.开发和优化基于假病毒的敏感检测方法,用于检测 HIV-1 中和抗体,使用 A3R5 细胞。
Hum Vaccin Immunother. 2018 Jan 2;14(1):199-208. doi: 10.1080/21645515.2017.1373922. Epub 2017 Oct 18.
8
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 and AAV1.通过依次给予AAV5和AAV1在小鼠和非人灵长类动物中成功实现重复肝脏基因递送。
Mol Ther. 2017 Aug 2;25(8):1831-1842. doi: 10.1016/j.ymthe.2017.05.003. Epub 2017 Jun 5.
9
Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.优化和验证 A3R5 细胞中 HIV-1 的中和抗体检测方法。
J Immunol Methods. 2014 Jul;409:147-60. doi: 10.1016/j.jim.2014.02.013. Epub 2014 Mar 6.
10
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.优化和验证 TZM-bl 测定法,用于标准化评估抗 HIV-1 的中和抗体。
J Immunol Methods. 2014 Jul;409:131-46. doi: 10.1016/j.jim.2013.11.022. Epub 2013 Dec 1.
验证荧光素酶报告基因检测法的参数,以检测多发性硬化症患者体内针对IFNβ的中和抗体。
J Immunol Methods. 2008 Jul 31;336(2):113-8. doi: 10.1016/j.jim.2008.03.014. Epub 2008 May 1.
4
Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.在荧光素酶报告基因检测中评估针对HIV、SIV和SHIV的中和抗体。
Curr Protoc Immunol. 2005 Jan;Chapter 12:12.11.1-12.11.17. doi: 10.1002/0471142735.im1211s64.
5
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.掩盖膜近端区域表位的1型人类免疫缺陷病毒糖蛋白41抗体:抗体结合动力学、诱导及急性感染中的调节潜力
J Virol. 2008 Jan;82(1):115-25. doi: 10.1128/JVI.00927-07. Epub 2007 Oct 17.
6
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.来自非洲南部急性和早期异性传播获得性感染的1型人类免疫缺陷病毒C亚型分子env克隆的遗传和中和特性
J Virol. 2006 Dec;80(23):11776-90. doi: 10.1128/JVI.01730-06. Epub 2006 Sep 13.
7
Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments.计算蛋白质组学分析系统(CPAS):一个用于评估和发布蛋白质组学数据及高通量生物学实验的可扩展开源分析系统。
J Proteome Res. 2006 Jan;5(1):112-21. doi: 10.1021/pr0503533.
8
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.来自急性和早期B亚型感染的1型人类免疫缺陷病毒env克隆,用于疫苗诱导中和抗体的标准化评估。
J Virol. 2005 Aug;79(16):10108-25. doi: 10.1128/JVI.79.16.10108-10125.2005.
9
The five-parameter logistic: a characterization and comparison with the four-parameter logistic.五参数逻辑斯蒂模型:一种特征描述及与四参数逻辑斯蒂模型的比较
Anal Biochem. 2005 Aug 1;343(1):54-65. doi: 10.1016/j.ab.2005.04.035.
10
The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.全球艾滋病毒/艾滋病疫苗企业:科学战略计划。
PLoS Med. 2005 Feb;2(2):e25. doi: 10.1371/journal.pmed.0020025. Epub 2005 Jan 18.